Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 7, 2026 | — | — | — | -0.53 | — |
| 2026 Q1 | May 12, 2026 | — | — | -0.52 | -0.52 | -2.79% |
| 2025 Q4 | March 16, 2026 | — | — | -0.50 | -0.51 | -3.25% |
| 2025 Q3 | November 10, 2025 | — | — | -0.49 | -0.44 | -1.59% |
| 2025 Q2 | August 11, 2025 | — | — | -0.51 | -0.43 | -0.75% |
| 2025 Q1 | May 13, 2025 | — | — | -0.36 | -0.49 | +4.22% |
| 2024 Q4 | March 18, 2025 | — | — | -0.51 | -0.63 | — |
| 2024 Q3 | November 19, 2024 | — | — | -0.60 | — | — |
| 2024 Q2 | August 6, 2024 | — | — | -0.54 | -0.54 | — |
| 2024 Q1 | May 8, 2024 | — | — | -0.56 | -0.53 | — |
| 2023 Q4 | March 11, 2024 | 1.88M | — | -0.49 | -0.49 | -0.17% |
| 2023 Q3 | November 7, 2023 | — | — | -0.48 | -0.51 | — |
| 2023 Q2 | August 8, 2023 | — | — | -0.49 | -0.73 | +2.94% |
| 2023 Q1 | May 9, 2023 | — | — | -0.70 | -0.66 | +10.65% |
| 2022 Q4 | March 9, 2023 | — | — | -0.65 | -0.65 | -0.76% |
| 2022 Q3 | November 8, 2022 | — | — | -0.57 | -0.79 | +9.43% |